Variable Sampling Interval for Blood Analyte Determinations

• US 20090054753A1
• Filed: 08/21/2007
• Published: 02/26/2009
• Est. Priority Date: 08/21/2007
• Status: Abandoned Application

• Current Assignee: Dave Mcmahon, Mark Ries Robinson, Mike Borrello
• Original Assignee: Dave Mcmahon, Mark Ries Robinson, Mike Borrello
• Inventors: Borrello, Mike, Robinson, Mark Ries, McMahon, Dave
• Application Number:
  US11/842,624
• Publication Number:
  US 20090054753A1
• Time in Patent Office: Days
• US Class Current: 600/365
• CPC Class Codes: A61B 5/14503 invasive, e.g. introduced into the body by a catheter or needle or using implanted sensors A61B5/1459, A61B5/1464, A61B5/1473, A61B5/1482, A61B5/14865 take precedence
• CPC Class Codes: A61B 5/14532 for measuring glucose, e.g. by tissue impedance measurement
• CPC Class Codes: G16H 40/63 for local operation
• CPC Class Codes: G16H 50/20 for computer-aided diagnosis, e.g. based on medical expert systems
• CPC Class Codes: G16H 50/50 for simulation or modelling of medical disorders
• CPC Class Codes: G16Z 99/00 Subject matter not provided for in other main groups of this subclass

Abstract

The present invention provides methods and apparatuses that can provide measurement of glucose with variable intervals between measurements, allowing more efficient measurement with greater patient safety. A method according to the present invention can comprise measuring the value of an analyte such as glucose at a first time; determining a second time from a patient condition, an environmental condition, or a combination thereof; then measuring the value of the analyte at the second time (where the second time can be expressed as an interval after the first time, an absolute time, or a time indicated when certain patient or environmental conditions, or both, are reached or detected). The second time can be determined, as an example, from a comparison of the analyte value at the first time with a threshold. The interval between the first time and the second time can be related to the difference between the analyte value at the first time and the threshold; e.g., the closer to the threshold, the closer the two measurement times. The invention can be used with automated measurement systems, allowing the system to determine measurement times and automatically make measurements at the determined times, reducing operator interaction and operator error.

Claims

1. A method of measuring an analyte in a patient, comprising:

a. Measuring the value of the analyte at a first time;

b. Measuring the value of the analyte at a second time;

c. Where the second time is determined from at least one patient condition, at least one environmental condition, or a combination thereof.

2. A method as in claim 1, wherein the second time is determined from a comparison of the value measured at the first time and a threshold value.

3. A method as in claim 2, wherein the elapsed time between the first time and the second time is less for a small difference between the first measured value and the threshold than for a larger difference between the first measured value and the threshold.

4. A method as in claim 1, wherein the analyte is glucose.

5. A method as in claim 1, wherein measuring the value of the analyte comprises using an automated measurement system to measure the value of the analyte.

26. A method as in claim 1, wherein the analyte is glucose concentration in blood, and wherein measuring the value of the analyte at a second time comprises withdrawing a blood sample from the patient using an automated system, determining the response of a portion of the blood sample to incident radiation, determining the glucose concentration in the blood sample from the determined response, and infusing at least a portion of the blood sample into the patient.

27. A method as in claim 1, wherein the analyte is glucose concentration in blood, and wherein measuring the value of the analyte at a second time comprises withdrawing a blood sample from the patient, producing a first portion of the blood sample having substantially no red blood cells, and measuring the glucose in the first portion.

28. A method as in claim 1, wherein the analyte is glucose concentration in blood, and wherein measuring the value of the analyte at a second time comprises withdrawing a blood sample from the patient, and measuring the glucose in the in the blood sample using a chemical sensor.

6. A method of measuring an analyte in a patient, comprising:

a. Measuring the value of the analyte at a plurality of times, with each pair of successive measurements separated by a time interval;

b. Wherein the time intervals are not all the same duration;

c. And wherein at least one time interval is determined from at least one patient condition, or at least one environmental condition, or a combination thereof.

7. A method as in claim 6, wherein at least one time interval is determined by predicting an duration where the value would reach a threshold value, where the prediction is based on one or more preceding measurements and one of:

one or more patient conditions, one or more environmental conditions, or a combination thereof; and

setting the interval based on the predicted duration.

8. A method as in claim 7, wherein the prediction is based on a linear extrapolation of two or more previous measurements.

9. A method as in claim 7, wherein the prediction is based on a nonlinear curve fitting of three or more previous measurements.

10. A method as in claim 7, wherein the prediction is based on a physiological model of the patient and on at least one preceding measurement.

11. A method as in claim 6, wherein a substance is infused into the patient, and wherein at least one time interval is determined from the nature of the infusate and the rate of infusion.

12. A method as in claim 6, wherein the analyte is glucose, and wherein glucose is infused into the patient, and wherein at least one time interval is determined from information related to the rate of glucose infusion.

13. A method as in claim 6, wherein the analyte is glucose, and wherein insulin is infused into the patient, and wherein at least one time interval is determined from information related to the rate of insulin infusion.

14. A method as in claim 6, wherein at least one time interval is determined by determining whether a change in a patient condition, a change in an environmental condition, or a combination thereof, indicates a measurement should be made.

15. A method as in claim 14, wherein determining whether a change in patient condition, a change in environmental condition, or a combination thereof, comprises applying a physiologic model to the patient'"'"'s condition, the environmental condition, or a combination thereof, and, if the physiological model indicates a glucose value that approaches a threshold value, then indicating that a measurement should be made.

16. A method as in claim 15, wherein the physiologic model comprises:

(a) a model based on the interactions illustrated in the Netter diagram, (b) an AIDA model, (c) a Chase model, (d) a Bergman model, (e) a compartment model with differential equations, (f) an insulin pharmacokinetics and distribution model, (g) a glucose pharmacokinetics and distribution model, (h) a meal model, (i) a glucose/insulin pharmacodynamic model, and (j) an insulin secretion and kinetics model, or (k) a combination of two or more of the preceding.

17. A method as in claim 6, wherein at least one time interval is determined by applying a physiologic model to the patient'"'"'s condition, environmental condition, or a combination thereof after the preceding measurement, and determining a duration for the time interval, and applying the model again after a change in the patient'"'"'s condition or environmental condition to determine an updated duration for the time interval, and indicating that a measurement be made after the updated duration.

18. A method as in claim 6, wherein the at least one time interval is determined from a combination of patient condition, environmental condition, or a combination thereof, and previous measurement values.

19. A method as in claim 15, wherein the physiologic model comprises information concerning preceding measured values in relation to patient condition, environmental condition, or a combination thereof.

20. A method as in claim 17, wherein the physiologic model comprises information concerning preceding measured values in relation to patient condition, environmental condition, or a combination thereof.

21. A method as in claim 6, wherein measuring the value of the analyte comprises using an automated measurement system to measure the value of the analyte.

22. A method as in claim 21, wherein measuring the value of the analyte comprises causing the automated measurement system to withdraw a sample of bodily fluid from the patient, measuring the analyte in at least a first portion of the sample, and returning at least a second portion of the sample to the patient.

23. A method as in claim 22, wherein the bodily fluid is blood, and the analyte is glucose, and wherein measuring the value of the analyte comprises determining the response of the first portion to incident radiation, and determining the analyte measurement from the determined response.

24. A method as in claim 21, wherein the bodily fluid is blood, and the analyte is glucose, and wherein the first portion comprises a portion of the blood sample that has substantially all the red blood cells removed.

25. A method as in claim 21, wherein measuring the value of the analyte comprises measuring the analyte with a chemical sensor.

29. An apparatus for measuring the value of an analyte at a plurality of times, comprising:

a. A fluid access system, adapted to withdraw a sample of a bodily fluid from a patient;

b. An analyte measurement system, adapted to measure the value of an analyte in a sample withdrawn from the patient by the fluid access system;

c. A controller, adapted to respond to a patient condition, an environment condition, or a combination thereof, and to cause the fluid access system to withdraw a sample for measurement by the analyte measurement system.

30. An apparatus as in claim 29, wherein the controller determines a time interval from a first sample withdrawal to a second sample withdrawal based on a patient condition, or an environment condition, or a combination thereof.

31. An apparatus as in claim 30, wherein the controller determines a time interval from a comparison of a value of the analyte in connection with the first sample and a threshold value.

32. An apparatus as in claim 31, wherein the controller determines a time interval that has a duration that is less for a small difference between the first measured value and the threshold than for a larger difference between the first measured value and the threshold.

33. An apparatus as in claim 30, wherein the controller predicts a duration until the analyte value will reach a threshold value, where the prediction is based on one or more preceding measurements and one of:

one or more patient conditions, one or more environmental conditions, or a combination thereof; and

wherein the controller causes the fluid access system to withdraw a sample for measurement based on the predicted duration.

34. An apparatus as in claim 33, wherein the controller predicts a duration by applying a physiologic model based on a patient condition, or an environmental condition, or a combination thereof.

35. An apparatus as in claim 30, wherein the bodily fluid is blood and the analyte is glucose.

36. An apparatus as in claim 31, wherein the bodily fluid is blood, the analyte is glucose, and the model is based on one or more previous glucose values.

37. An apparatus as in claim 34, wherein the model is further based on information related to a rate of glucose infusion.

38. An apparatus as in claim 34, wherein the model is further based on information related to a rate of insulin infusion.

39. An apparatus as in claim 34, wherein the model is further based on the patient'"'"'s previous response to glucose infusion, or insulin infusion, or a combination thereof.

40. An apparatus as in claim 29, wherein the fluid access system comprises a fluidics system, adapted to remove blood from a body, transport a portion of the removed blood to an analyte measurement system for measurement, infuse a portion of the blood measured by the analyte measurement system back into the patient, flow a maintenance substance to the analyte measurement system without infusing a substantial amount of the maintenance substance into the patient.

41. An apparatus as in claim 29, wherein the fluid access system comprises

a. a blood removal element, adapted to communicate blood with the circulatory system of a patient;

b. a source of maintenance fluid;

c. a waste channel;

d. a fluid control system, in fluid communication with and adapted to control fluid flow among the blood removal element, the analyte measurement system, the source of maintenance fluid; and

the waste channel.